Premature Ventricular Complexes and Nonsustained Ventricular Tachycardia in Cardiac Sarcoidosis
JACC: Clinical Electrophysiology · 2025
DOI: 10.1016/j.jacep.2025.03.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2025. Verfasst von Jose F de Melo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Sarcoidosis, Tachycardia, Ventricular, Ventricular Premature Complexes, Cardiomyopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The prevalence and prognostic significance of frequent premature ventricular complexes (PVCs) and nonsustained ventricular tachycardia (NSVT) in cardiac sarcoidosis (CS), especially in patients with normal or mildly decreased left ventricular function, have not been studied. OBJECTIVES: This study sought to investigate the prognostic value of PVCs and NSVT in patients with CS and normal or mildly decreased left ventricular ejection fraction. METHODS: The authors included 192 patients with definite or probable CS with left ventricular ejection fraction >35% and no previous history of ventricular tachycardia (VT)/ventricular fibrillation (VF) or sudden cardiac death, who underwent up to 48 hours of clinically indicated Holter monitoring. Baseline PVC burden and presence of NSVT were correlated with presence of fluorodeoxyglucose (FDG) uptake on positron emission tomography and late gadolinium enhancement (LGE) on magnetic resonance imaging. They performed multivariable analysis for the associations of PVC burden and NSVT with the composite endpoint of sustained VT/VF, advanced heart failure therapy, and all-cause mortality. RESULTS: The median PVC burden was 0.3% (Q1-Q3: 0.02%-2.5%), and 36 (18.8%) patients had PVC burden ≥5%. Sixty-two patients (32.3%) had NSVT detected during Holter monitoring. PVC burden and NSVT had an association with LGE presence but not with FDG uptake. A total of 33 patients (17.2%) experienced the composite endpoint during a median follow-up of a 3 years. In multivariable analysis, PVC burden ≥5% vs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: siontis.konstantinos@mayo.edu.
Zitieren
APA
de Melo, J. F., Debertin, J., Castrichini, M., Rosenbaum, A. N., Bois, J. P., Giudicessi, J. R., Kafil, T. S., Deshmukh, A. J., Kapa, S., Sugrue, A. M., Killu, A. M., Del-Carpio Munoz, F., DeSimone, C. V., Kowlgi, G., Tan, N. Y., Ezzeddine, F. M., Asirvatham, S. J., Abou Ezzeddine, O. F., & Siontis, K. C. (2025). Premature Ventricular Complexes and Nonsustained Ventricular Tachycardia in Cardiac Sarcoidosis. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2025.03.015
Vancouver
de Melo JF, Debertin J, Castrichini M, Rosenbaum AN, Bois JP, Giudicessi JR, et al. Premature Ventricular Complexes and Nonsustained Ventricular Tachycardia in Cardiac Sarcoidosis. JACC: Clinical Electrophysiology. 2025. doi:10.1016/j.jacep.2025.03.015
BibTeX
@article{deMelo2025,
author = {de Melo, Jose F and Debertin, Julia and Castrichini, Matteo and Rosenbaum, Andrew N and Bois, John P and Giudicessi, John R and Kafil, Tahir S and Deshmukh, Abhishek J and Kapa, Suraj and Sugrue, Alan M and Killu, Ammar M and Del-Carpio Munoz, Freddy and DeSimone, Christopher V and Kowlgi, Gurukripa and Tan, Nicholas Y and Ezzeddine, Fatima M and Asirvatham, Samuel J and Abou Ezzeddine, Omar F and Siontis, Konstantinos C},
title = {Premature Ventricular Complexes and Nonsustained Ventricular Tachycardia in Cardiac Sarcoidosis},
journal = {JACC: Clinical Electrophysiology},
year = {2025},
doi = {10.1016/j.jacep.2025.03.015}
}
EUVIMED